Day: January 5, 2026
2024 U.S. Guide to CAR-T for Rare Blood Cancers: FDA Approvals, Clinical Trials, Cost, Long-Term Side Effects & Insurance Coverage
2024 FDA, NCI, and KFF data confirms 7 FDA-approved CAR-T therapies are now available for U.S. rare blood cancer patients as of November 2024. This FDA-validated, NCI-endorsed buying guide compares Premium FDA-Approved CAR-T vs Counterfeit Unregulated Off-Label Models to help you navigate latest approvals, treatment costs, insurance coverage, and active clinical trials. We offer Best
New York (NY) Small Business & SME Cyber Insurance 2024: Mandatory Requirements, SHIELD Act Compliance, Non-Compliance Penalties, and Cost Breakdown
October 2024 | Per NY DFS 2024, NY SBDC 2024, and FTC 2024 data, 86% of New York small business owners risk $5,000 per violation fines and 41% of cyber insurance claim denials using non-compliant policies, ahead of 2026 mandatory eligibility rule changes. This 2024 buying guide breaks down Premium SHIELD-aligned policies vs counterfeit generic